In addition, IM treatment of murine LT-CML stem cells in vitro reduced levels of phospho-p38MAPK and phospho-Smad3–Ser208 (Supplementary Fig. 11). The gene discussed is SMAD3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.